Ayr Wellness Inc Ordinary Shares (Sub, Restricted, Ltd Voting) AYRWF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AYRWF is a good fit for your portfolio.
News
-
AYR Wellness to Hold First Quarter 2024 Conference Call on May 15 at 8:30 a.m. ET
-
Florida Supreme Court OKs adult-use cannabis referendum for November ballot in victory for pot companies
-
AYR Wellness Launches kynd Premium Edibles in Florida and Nevada
-
AYR Wellness Announces Upsizing of Gainesville Cultivation Facility Mortgage
-
What New Jersey did right - and New York did wrong - with recreational-cannabis launches
-
Cannabis stocks extend gains after Biden White House shows support of marijuana reforms
-
Cresco Labs' stock rallies as cannabis company swings to a profit
-
AYR Wellness Reports Fourth Quarter and Full Year 2023 Results
Trading Information
- Previous Close Price
- $2.58
- Day Range
- $2.36–2.60
- 52-Week Range
- $0.67–4.09
- Bid/Ask
- $2.41 / $2.47
- Market Cap
- $273.70 Mil
- Volume/Avg
- 84,143 / 383,310
Key Statistics
- Price/Earnings (Normalized)
- 1.43
- Price/Sales
- 0.41
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ayr Wellness Inc is a vertically integrated, U.S. multi-state cannabis operator. IT engaged in the cultivation, manufacturer, and retailer of cannabis products and branded cannabis packaged goods. It operates in one operating segment, cannabis sales.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,300
- Website
- https://www.ayrwellness.com
Comparables
Valuation
|
Metric
|
AYRWF
|
TSND
|
GLAS.A.U
|
|---|---|---|---|
Price/Earnings (Normalized) | 1.43 | 23.09 | — |
Price/Book Value | 0.34 | 2.13 | 6.86 |
Price/Sales | 0.41 | 1.55 | 3.89 |
Price/Cash Flow | — | — | 66.76 |
Price/Earnings
AYRWF
TSND
GLAS.A.U
Financial Strength
|
Metric
|
AYRWF
|
TSND
|
GLAS.A.U
|
|---|---|---|---|
Quick Ratio | 0.32 | 0.21 | 0.38 |
Current Ratio | 0.96 | 0.50 | 0.56 |
Interest Coverage | −0.18 | −0.68 | −7.98 |
Quick Ratio
AYRWF
TSND
GLAS.A.U
Profitability
|
Metric
|
AYRWF
|
TSND
|
GLAS.A.U
|
|---|---|---|---|
Return on Assets (Normalized) | 2.99% | 2.75% | −7.03% |
Return on Equity (Normalized) | 7.00% | 6.75% | −18.64% |
Return on Invested Capital (Normalized) | 6.00% | 8.44% | −6.32% |
Return on Assets
AYRWF
TSND
GLAS.A.U
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hwptvcyldp | Mdr | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Hhnzgqls | Gzpwfd | $69.8 Bil | |
HLN
| Haleon PLC ADR | Hhmhzssk | Tgp | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Hbffdqkxw | Kcmym | $14.6 Bil | |
VTRS
| Viatris Inc | Rvxrrwfbc | Plhf | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lxkfngjj | Crpt | $12.6 Bil | |
CTLT
| Catalent Inc | Lbszbrs | Mctwsj | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Rgbqfjcj | Rdd | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Rfpjrbsx | Bgc | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pgwxwvygy | Sxntdl | $3.6 Bil |